Biotech Scoreboard, November: Gene Therapy Stocks Gain Momentum
Here is the review we did on June 30 after a Barron’s article on the sector.
IBB up 11.2% for November, XBI up 6.3%, but NASDAQ-100 (QQQ) leads up 14.5 %.
Big Winners for the Month: NTLA up 47.24%, EDIT up 41.5%, CRSP up 37.68%, SRPT up 34%,
| Company | Symbol | Price | Price at | Price | Mo./% | YTD % | ||
| 6/29/19 | 52 wk hi | 11/30 | ||||||
| Audentes Therap | BOLD | 37.86 | 42.7 | 1.67 | 29.03 | 14.5 | 30.71 | |
| MetraGTx | MGTX | 26.88 | 27 | 0.896 | 19.27 | 10.2 | 95.93 | |
| RegenexBio | RGNX | 51.37 | 85.1 | 1.88 | 41.86 | 21.2 | (3.390 | |
| Solid Biosci | SLDB | 5.75 | 54.54 | 0.37 | 3.93 | -65.13 | -86.41 | |
| uniQure | QURE | 78.15 | 82.49 | 2.95 | 55.66 | 14.5 | 95 | |
| Voyager Therap | VYGR | 27.22 | 28.79 | 0.612 | 13.64 | 14.49 | 44.8 | |
| Diversified Plays | ||||||||
| Biomarin | BMRN | 85.65 | 106.74 | 15.337 | 80.71 | 9.8 | -5 | |
| Sarepta | SRPT | 151.95 | 165.87 | 11.27 | 112.49 | 34.04 | 4.64 | |
| Other | ||||||||
| Amicus | FOLD | 12.48 | 16.82 | 3.174 | 10.48 | 26.4 | 4.36 | |
| bluebird bio | BLUE | 127.2 | 183.6 | 7.012 | 80.94 | -2.7 | -18.65 | |
| Gene Editing | ||||||||
| CRSPR Therap | CRSP | 47.1 | 66.26 | 2.58 | 71.65 | 37.68 | 139.87 | |
| Editas Medicine | EDIT | 24.74 | 38.77 | 1.22 | 30.28 | 41.5 | 29.73 | |
| Intellia Therap | NTLA | 16.37 | 35.3 | 0.748 | 17.33 | 47.24 | 25.5 | |
| Sangamo Ther | SGMO | 10.77 | -3.9 | 1.24 | 10.8 | 16.8 | -8.32 | |
| Cellectis S.A. | CLLS | 13.9 | 16 | -19.94 | ||||
| IBB | 109.1 | 122.97 | 119.65 | 11.2 | 22.72 | |||
| XBI | 87.71 | 101.17 | 93.65 | 6.3 | 28.53 | |||
| QQQ | 205.17 | 14.5 | 32.43 | |||||
Disclosure: None.
How did you like this article? Let us know so we can better customize your reading experience.
Comments
Leave a comment to automatically be entered into
our contest to win a free Echo Show.
